Cougar Biotechnology, Inc. (NASDAQ CGRB) announced today that the initial offering period of Johnson & Johnsons (NYSE JNJ) tender offer for all the outstanding shares of Cougar common stock expired at midnight (Eastern time) on July 2, 2009. The offer was conducted through a whollyowned subsidiary of Johnson & Johnson named Kite Merger Sub, Inc. [...]

Intervet/ScheringPlough Animal Health, the global leader in veterinary biologicals, announced the availability of the first vaccine against canine influenza virus (CIV), which was granted a conditional product license by the U.S. Department of Agriculture (USDA) on May 27, 2009, for use by veterinarians in the United States.
“Canine influenza is a highly contagious [...]

Two studies from AstraZeneca (NYSE AZN) show that symptomatic gastroesophageal reflux disease (GERD) patients treated with NEXIUM(R) (esomeprazole magnesium) 20 mg daily experienced greater relief from nighttime heartburn and GERDrelated sleep disturbances compared with patients taking placebo over four weeks(1). NEXIUM 20 mg is indicated for the treatment of heartburn and other symptoms associated [...]